VOYA Investment Management
CERE

VOYA Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

VOYA Investment Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34,210
Closed -$1.4M – 2865
2024
Q2 		$1.4M Buy
34,210
+11,390
+50% +$474K ﹤0.01% 1450
2024
Q1 		$965K Sell
22,820
-41,224
-64% -$1.73M ﹤0.01% 1650
2023
Q4 		$2.72M Buy
64,044
+39,319
+159% +$1.13M ﹤0.01% 1252
2023
Q3 		$540K Buy
24,725
+264
+1% +$6.61K ﹤0.01% 1990
2023
Q2 		$778K Buy
24,461
+2,982
+14% +$91.5K ﹤0.01% 1830
2023
Q1 		$524K Hold
21,479
– – ﹤0.01% 2028
2022
Q4 		$677K Buy
21,479
+507
+2% +$14.3K ﹤0.01% 1856
2022
Q3 		$593K Buy
20,972
+496
+2% +$14.8K ﹤0.01% 1925
2022
Q2 		$541K Buy
20,476
+4,174
+26% +$119K ﹤0.01% 1787
2022
Q1 		$571K Buy
16,302
+593
+4% +$17.3K ﹤0.01% 1830
2021
Q4 		$509K Buy
15,709
+345
+2% +$12.2K ﹤0.01% 1997
2021
Q3 		$453K Buy
15,364
+1,342
+10% +$37.7K ﹤0.01% 2108
2021
Q2 		$359K Buy
+14,022
New +$201K ﹤0.01% 2288

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VOYA Investment Management's CERE Position: Q3 2024 in Review

VOYA Investment Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 34,210 shares — an estimated $1.4M sold.

VOYA Investment Management first reported a position in CERE in Q2 2021 and held it in 13 quarters. The position peaked at $2.72M in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • VOYA Investment Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • VOYA Investment Management sold 34,210 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.4M.
  • VOYA Investment Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • VOYA Investment Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $2.72M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on VOYA Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.